Plus: Zyn can now be marketed as a safe alternative to cigarettes and Jalen Brunson is now a salad mogul.
Plus: Trump bought Axon stock right before a $220 million ICE Taser deal, Rocket Lab is trying to catch up to SpaceX, and the consultant's billable hour is under existential threat.
Plus: Anthropic drops Claude for Slack, Wimbledon debenture seats are now fetching over $500,000, and Oracle cut 21K jobs over the past year.
Plus: SpaceX disclosed $100 billion in cash, the stock still dropped 16%, and Bain & Co. is using AI vibe coding to build software replicas for private equity due diligence.
Plus: Blankfein is day-trading without a computer, private credit redemptions keep accelerating, and Allbirds' AI rebranding.
Plus: Alphabet needs $80 billion to keep up in AI, Barry Diller wants to take MGM private, and a room full of billionaire heirs is paying to find meaning.
Plus: A $67 billion utility merger, BDCs pricing in Covid-level pain, and xAI stiffing its own employees on $420 tax reimbursements
Plus: A new Fed Chair, the biggest IPO in history on the horizon, and the DOJ probing private credit valuations.
Plus: Anthropic is closing in on a $900 billion valuation, eBay swatted away GameStop, and Goldman's own president is calling the bank a human assembly line.
Plus: JPM's sex scandal accuser rejected a $1M settlement, Anthropic is doing compute deals in space, and Wall Street is lining up data center IPOs.
Plus: Anthropic is coming for the analyst class, bots are taking over bond trading, and Morgan Stanley's Budapest operation is under federal scrutiny.
Plus: AI is lifting GDP, Nvidia and Meta had rough days, and Ozempic breath causing tailwinds in gum industry.
